SEC Form 4 · accession 0000899243-17-003471
AVEO PHARMACEUTICALS INC · AVEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Keith S Ehrlich
Officer — Chief Financial Officer
Period of report
Feb 8, 2017
Accepted (ET)
Feb 10, 2017 · 4:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001325879
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.60 | Feb 8, 2017 | A | 170,000 | A | — | Feb 7, 2027 | Common Stock | 170,000 | 170,000 | D |
Explanation of responses
- F1The shares underlying this option vest in equal monthly installments from February 8, 2017, through February 8, 2021, subject to the Reporting Person's continued service to the Company.